|Bid||10.47 x 3000|
|Ask||10.49 x 1100|
|Day's Range||10.28 - 11.27|
|52 Week Range||3.71 - 19.68|
|Beta (5Y Monthly)||3.20|
|PE Ratio (TTM)||48.43|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The latest cannabis company to turn a profit was Tilray (NASDAQ: TLRY), achieving that mark earlier than both Aurora Cannabis (NYSE: ACB) and Canopy Growth (NASDAQ: CGC). Let's take a look at what changed for Tilray this quarter and whether it is a better buy than two of its key rivals. Tilray comes through on its promise -- but should investors be impressed?
Canopy Growth launched CBD beverages in the U.S. on Tuesday. Canopy Growth stock rose while other marijuana stocks were mixed.
More than a dozen states could consider recreational pot legalization this year, as New Jersey and Virginia move forward.